BC Extra | Oct 4, 2019
Financial News

Oct. 4 Financial Quick Takes: Innovent raises $300M in Hong Kong's first biotech follow-on; plus Oyster Point, Heron, Molecular Assemblies and Geneoscopy

Innovent brings in first follow-on of HKEX's biotech chapter  A year after going public on the Hong Kong stock exchange, Innovent Biologics Inc. (HKEX:1801) raised HK$2.4 billion ($299.8 million) through the sale of 97 million...
BC Extra | Oct 3, 2019
Company News

Oct. 2 Company Quick Takes: Merck, Immunovant, PureTech-Ariya, Viscient-Organovo and Durect

China approves Keytruda monotherapy for 1L NSCLC  China's National Medical Products Administration approved PD-1 inhibitor Keytruda pembrolizumab from Merck & Co. Inc. (NYSE:MRK) as a monotherapy for first-line treatment of locally advanced or metastatic non-small...
BC Innovations | Sep 13, 2019
Tools & Techniques

Enzymes aim to beat chemistry by creating longer, speedier, cleaner DNA strands

The first new chemistry for DNA writing in 30 years is gathering steam, with enzymatic synthesis startups developing platforms to generate longer, purer DNA strands in record time. While the new players aim to outperform...
BioCentury | Dec 14, 2018
Finance

Mission: Mainstream

Mission Bio Inc. plans to deploy its $30 million series B round to expand the applications and client base for its single-cell DNA analysis platform. Agilent Technologies Inc. (NYSE:A), Cota Capital, Laboratory Corp. of America...
BC Week In Review | Dec 14, 2018
Financial News

Mission Bio raises $30M series B to expand Tapestri’s reach

Precision genomics company Mission Bio Inc. (South San Francisco, Calif.) raised $30 million on Dec. 13 in an untranched series B round from Agilent Technologies (NYSE:A), Cota Capital, Laboratory Corp. of America Holdings (NYSE:LH), LAM...
BC Extra | Dec 13, 2018
Financial News

Mission Bio raises $30M series B to expand Tapestri’s reach

Precision genomics company Mission Bio Inc. (South San Francisco, Calif.) raised $30 million in an untranched series B round from Agilent Technologies (NYSE:A), Cota Capital, Laboratory Corp. of America Holdings (NYSE:LH), LAM Research Capital and...
BC Week In Review | Sep 28, 2018
Company News

Agilent acquires tools company Acea to expand China footprint

Agilent Technologies Inc. (NYSE:A) acquired cell analysis tools company Acea Biosciences Inc. (San Diego, Calif.) for $250 million. Agilent said the acquisition will expand the company's capabilities in China, where Acea has a large manufacturing...
BC Extra | Aug 2, 2018
Company News

Management tracks: Omeros, EdiGene

Omeros Corp. (NASDAQ:OMER) hired Eckhard Leifke as CMO and VP of clinical development. He was global project head/VP of early project and external opportunities - cardiovascular and metabolism and global head/VP of late-stage development diabetes at...
BC Extra | Aug 1, 2018
Company News

Management tracks: Hologic, Tricidia

Hologic Inc. (NASDAQ:HOLX) said Bob McMahon has departed as CFO to become CFO at Agilent Technologies Inc. (NYSE:A). The diagnostics company promoted Chief Accounting Officer Karleen Oberton to CFO. Metabolic acidosis play Tricida Inc. (NASDAQ:TCDA)...
BC Week In Review | Jun 15, 2018
Clinical News

FDA approves Keytruda in cervical cancer, PMBCL

Merck & Co. Inc. (NYSE:MRK) said FDA granted accelerated approval to Keytruda pembrolizumab to treat recurrent or metastatic cervical cancer with disease progression on or after chemotherapy in patients whose tumors express PD-L1, with a...
Items per page:
1 - 10 of 237
BC Extra | Oct 4, 2019
Financial News

Oct. 4 Financial Quick Takes: Innovent raises $300M in Hong Kong's first biotech follow-on; plus Oyster Point, Heron, Molecular Assemblies and Geneoscopy

Innovent brings in first follow-on of HKEX's biotech chapter  A year after going public on the Hong Kong stock exchange, Innovent Biologics Inc. (HKEX:1801) raised HK$2.4 billion ($299.8 million) through the sale of 97 million...
BC Extra | Oct 3, 2019
Company News

Oct. 2 Company Quick Takes: Merck, Immunovant, PureTech-Ariya, Viscient-Organovo and Durect

China approves Keytruda monotherapy for 1L NSCLC  China's National Medical Products Administration approved PD-1 inhibitor Keytruda pembrolizumab from Merck & Co. Inc. (NYSE:MRK) as a monotherapy for first-line treatment of locally advanced or metastatic non-small...
BC Innovations | Sep 13, 2019
Tools & Techniques

Enzymes aim to beat chemistry by creating longer, speedier, cleaner DNA strands

The first new chemistry for DNA writing in 30 years is gathering steam, with enzymatic synthesis startups developing platforms to generate longer, purer DNA strands in record time. While the new players aim to outperform...
BioCentury | Dec 14, 2018
Finance

Mission: Mainstream

Mission Bio Inc. plans to deploy its $30 million series B round to expand the applications and client base for its single-cell DNA analysis platform. Agilent Technologies Inc. (NYSE:A), Cota Capital, Laboratory Corp. of America...
BC Week In Review | Dec 14, 2018
Financial News

Mission Bio raises $30M series B to expand Tapestri’s reach

Precision genomics company Mission Bio Inc. (South San Francisco, Calif.) raised $30 million on Dec. 13 in an untranched series B round from Agilent Technologies (NYSE:A), Cota Capital, Laboratory Corp. of America Holdings (NYSE:LH), LAM...
BC Extra | Dec 13, 2018
Financial News

Mission Bio raises $30M series B to expand Tapestri’s reach

Precision genomics company Mission Bio Inc. (South San Francisco, Calif.) raised $30 million in an untranched series B round from Agilent Technologies (NYSE:A), Cota Capital, Laboratory Corp. of America Holdings (NYSE:LH), LAM Research Capital and...
BC Week In Review | Sep 28, 2018
Company News

Agilent acquires tools company Acea to expand China footprint

Agilent Technologies Inc. (NYSE:A) acquired cell analysis tools company Acea Biosciences Inc. (San Diego, Calif.) for $250 million. Agilent said the acquisition will expand the company's capabilities in China, where Acea has a large manufacturing...
BC Extra | Aug 2, 2018
Company News

Management tracks: Omeros, EdiGene

Omeros Corp. (NASDAQ:OMER) hired Eckhard Leifke as CMO and VP of clinical development. He was global project head/VP of early project and external opportunities - cardiovascular and metabolism and global head/VP of late-stage development diabetes at...
BC Extra | Aug 1, 2018
Company News

Management tracks: Hologic, Tricidia

Hologic Inc. (NASDAQ:HOLX) said Bob McMahon has departed as CFO to become CFO at Agilent Technologies Inc. (NYSE:A). The diagnostics company promoted Chief Accounting Officer Karleen Oberton to CFO. Metabolic acidosis play Tricida Inc. (NASDAQ:TCDA)...
BC Week In Review | Jun 15, 2018
Clinical News

FDA approves Keytruda in cervical cancer, PMBCL

Merck & Co. Inc. (NYSE:MRK) said FDA granted accelerated approval to Keytruda pembrolizumab to treat recurrent or metastatic cervical cancer with disease progression on or after chemotherapy in patients whose tumors express PD-L1, with a...
Items per page:
1 - 10 of 237